ClassID:

109761

C12N2710/16022 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20260062730
2026-03-05

CHIMERIC INVASIN SYSTEM

#2
20250340903
2025-11-06

Modified Herpes Simplex Virus Type 1

#3
20250325585
2025-10-23

COMPOSITIONS AND METHODS FOR REDUCING CELL THERAPY IMMUNOGENICITY

#4
20250283069
2025-09-11

GENE-DRIVE IN DNA VIRUSES

#5
20250000966
2025-01-02

MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE

#6
20240248080
2024-07-25

Kaposi sarcoma associated herpesvirus gene function

#7
20230242589
2023-08-03

CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND THEIR USE IN CAR-T CELLS

#8
20230151438
2023-05-18

VIRAL DETECTION ASSAY

#9
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

#10
20230096087
2023-03-30

PREFUSION-STABILIZED HERPESVIRUS GLYCOPROTEIN-B

#11
20220340884
2022-10-27

VACCINES FOR TREATING SARS INFECTIONS IN CANCER PATIENTS

#12
20220193227
2022-06-23

Recombinant virus with diminished latency and methods of using same

#13
20210222150
2021-07-22

GENE-DRIVE IN DNA VIRUSES

#14
20190167784
2019-06-06

Recombinant virus with diminished latency and methods of using same

#15
20190031723
2019-01-31

Truncated glycoprotein G of herpes simplex virus 2

#16
20190025306
2019-01-24

Enzyme-linked immunoassay to detect gammaherpesvirus 1

#17
20180230439
2018-08-16

Altered avian virus for in-ovo inoculation and methods of use thereof

#18
20170224808
2017-08-10

THERAPEUTIC COMPOSITIOJNS AND METHODS FOR INDUCING AN IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS TYPE 2 (HSV-2)

#19
20170028057
2017-02-02

Koi herpesvirus vaccine

#20
20150175661
2015-06-25

GPCR with improved cell surface expression

#21
20130209506
2013-08-15

Recombinant virus with diminished latency and methods of using same

#22
20120195927
2012-08-02

gM-negative EHV-mutants without heterologous elements

#23
20120070892
2012-03-22

DNA virus MicroRNA and methods for inhibiting same

#24
20110039916
2011-02-17

Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof

#25
20100184205
2010-07-22

Nucleic acids involved in viral infection

#26
20100178684
2010-07-15

TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF

#27
20100120092
2010-05-13

RECOMBINANT PROTEINS AND VIRUS LIKE PARTICLES COMPRISING L AND S POLYPEPTIDES OF AVIAN HEPADNAVIRIDAE AND METHODS, NUCLEIC ACID CONSTRUCTS, VECTORS AND HOST CELLS FOR PRODUCING SAME

#28
20090191239
2009-07-30

Recombinant infectious laryngotracheitis virus and uses thereof

#29
20090162396
2009-06-25

GM-negative EHV-mutants without heterologous elements

#30
20090068223
2009-03-12

COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS

#31
20090060951
2009-03-05

DNA vaccine for Koi herpes virus (KHV) disease

#32
20080175859
2008-07-24

Recombinant infectious laryngotracheitis virus and uses thereof

#33
20070212377
2007-09-13

Recombinant herpesvirus and uses thereof

#34
20070166330
2007-07-19

gM-negative EHV-mutants without heterologous elements

#35
20060111558
2006-05-25

Recombinant infectious laryngotracheitis virus and uses thereof

#36
20050239052
2005-10-27

Cloning of rhadinovirus genome and methods for its use

#37
20050222067
2005-10-06

DNA virus microRNA and methods for inhibiting same

#38
20050153891
2005-07-14

Viral protein binding compositions and methods